Utah Medical Products
This article was originally published in The Gray Sheet
Executive Summary
Will begin shipments of its Toco Bubble in approximately one month. The dynamometer device is designed to measure uterine contraction during labor and delivery. The firm began taking orders for the device immediately after receiving FDA 510(k) clearance for the product on June 4. The company says the Toco Bubble, which is several inches in diameter and adheres directly to the abdomen, is intended to replace belt devices that currently are used to measure uterine contractions. The device is disposable and sells for $5 to hospitals. The firm sells connector tubing and a reusable adaptor designed to connect the device to a monitor separately. On June 15, Utah announced that it no longer is under investigation by the Securities and Exchange Commission. Records subpoenaed in 1992 by the Department of Justice, Utah district, recently were returned to the company. Although it never was informed of the reasons for the investigation, the company says it may have been in connection with the indictment of former president and CEO William Dean Wallace on charges that included insider trading and falsification of firm records. Wallace was acquitted in December 1992 ("The Gray Sheet" Jan. 4, In Brief).
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.